Healthcare101

 The global  eClinical Solutions Market  is expected to grow from USD 11.6 billion in 2024 to USD 22.1 billion by 2029, at a CAGR of 13.7%. eClinical solutions have significantly enhanced clinical trial efficiency, site performance, and cost-effectiveness compared to traditional methods, driving their market growth. These solutions, including electronic data capture (EDC) and clinical data management systems (CDMS), streamline operations and ensure regulatory compliance, benefiting contract research organizations (CROs), researchers, and pharmaceutical companies. Despite high implementation costs and concerns over patient privacy, the market is expanding due to increased adoption of novel software, rising clinical trials in developing countries, and the growing need for efficient data management. The electronic clinical outcome assessment (eCOA) solutions segment is expected to grow the fastest, driven by improved data accuracy and patient engagement. ...

 The mRNA synthesis and manufacturing market is projected to reach USD 2.96 billion by 2029 from USD 2.23 billion in 2024, at a CAGR of 5.8% from 2024 to 2029. The market growth is fueled by rising demand in clinical trials for mRNA vaccines, along with the increased outsourcing of mRNA synthesis and production. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105705347 Browse in-depth TOC on “mRNA Synthesis & Manufacturing Market” 250 — Tables 50 — Figures 250 — Pages KEY TAKEAWAYS The North America mRNA synthesis & manufacturing market accounted for a 47.1% revenue share in 2024. By product, the instruments segment is expected to register the highest CAGR of 5.8% By service, the mRNA synthesis & modification services segment is expected to register the highest CAGR of 7.6% By application, the cell & gene therapies segment is projected to grow at the fastest rate from 2024 to 2029. By end user (product), the pharmaceutical & biotec...

 The global Injectable Drug Delivery Market , valued at US$633.7 billion in 2024, is forecasted to grow at a robust CAGR of 8.4%, reaching US$690.23 billion in 2025 and an impressive US$1,034.78 billion by 2030. The injectable drug delivery market is driven by the rising prevalence of chronic diseases, such as diabetes, cancer, and autoimmune disorders, alongside an increasing global demand for biologics. Developed markets like the US, Germany, and Japan continue to adopt advanced delivery technologies, supported by strong healthcare infrastructure and patient preference for convenient, self-administered therapies. In emerging markets such as India, Brazil, and China, market growth is accelerated by improved healthcare access and government-backed immunization and chronic disease management programs. Key market trends include the increasing adoption of wearable injectors, autoinjectors, and needle-free systems. This shift is largely driven by a growing emphasis on patient complianc...

 The global Sleep Apnea Devices Market , valued at US$6.4 billion in 2024 stood at US$6.9 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2032, culminating in a forecasted valuation of US$11.6 billion by the end of the period. The sleep apnea devices market is experiencing significant growth, primarily driven by the increasing integration of telemedicine, mobile health (mHealth), and artificial intelligence in the diagnostic and therapeutic processes for sleep apnea. The expansion of key market players into emerging economies like India, Australia, the UAE, and Saudi Arabia is further enhancing this market’s potential. Additionally, there is a notable trend among health agencies to expand reimbursement policies for remote patient monitoring and related connected healthcare services, which is improving accessibility to advanced sleep apnea management solutions. Furthermore, innovative developments such as compact positive airway pressure (PAP) de...

 The global Single-use Bioprocessing Market , valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2025 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. Some factors contributing to the growth of the global single-use bioprocessing market include the growing adoption among contract development & manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs), the increased productivity, and the reduced risk of cross-contamination. Moreover, reduced capital investment and the thriving biologics & biosimilar markets bolster the market growth. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297 Browse in-depth TOC on “ Single Use Bioprocessing Market “ 740 — Tables 65 — Figures 570 — Pages Based on region , the single-use bioprocessing market is segmented into six major regions, namely North Americ...

 The global cell therapy technologies market , valued at US$3.89 billion in 2023 , stood at US$4.03 billion in 2024 and is projected to advance at a robust CAGR of 11.0% from 2024 to 2029 , reaching a forecasted valuation of US$6.80 billion by the end of the period. This growth underscores the transformative potential of cell therapy technologies in modern healthcare, driven by advancements in regenerative medicine , increasing R&D investments , and the rising prevalence of chronic and rare diseases worldwide. Emerging trends such as the integration of artificial intelligence (AI) and machine learning (ML) into cell therapy workflows are revolutionizing the industry by optimizing production processes, enhancing precision, and improving therapeutic outcomes. Moreover, the shift toward allogeneic cell therapies , offering scalability and wider accessibility, is further propelling market expansion. The rise of cell and gene therapy hubs across North America, Europe, and Asi...

 The global biopharmaceutical contract manufacturing market , valued at US$20.51 billion in 2024 , stood at US$22.40 billion in 2025 and is projected to grow at a CAGR of 8.8% from 2025 to 2030, reaching a forecasted US$34.15 billion by 2030 . This robust growth reflects the rising global demand for outsourcing services, fueled by increasing biologics and biosimilars production, as well as the expanding prevalence of chronic and rare diseases. However, the market faces certain barriers related to intellectual property (IP) rights and compliance with stringent regulatory frameworks. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163964739 Attractive Opportunities in the Biopharmaceutical Contract Manufacturing Market The biopharmaceutical contract manufacturing market presents strong opportunities across multiple regions, with Asia Pacific emerging as a particularly attractive hub. The growth of the Asia Pacific market is driven by: ...

  The report   " 3D Bioprinting Market  by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029" , is projected to reach USD 2.4 billion by 2029 from USD 1.3 billion in 2024, at a CAGR of 12.7% during the forecast period The growth in the 3D bioprinting market is fueled by  growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries, advancement in the 3D bioprinting technology, rising public and private partnerships and collaborations, increasing investments in R&D and the expenditure on medical devices. Browse 530 market data Tables and 46 Figures spread through 453 Pages and in-depth TOC on  "3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM)...

  The global  vaccine storage equipment market , valued at   US$0.82 billion   in 2023, is forecasted to grow at a robust CAGR of 7.2%, reaching   US$0.86 billion   in 2024 and an impressive   US$1.21 billion   by 2029. Innovation in technology and regulatory changes are changing the landscape of the vaccine storage equipment market. Automation is improving efficiency by offering real-time monitoring and control of critical components like temperature. This also helps in reducing energy consumption and operational costs while increasing the quality of the product. Another significant driving factor is the escalation in conditions necessitating vaccination is creating a conducive environment for market expansion. The diseases such as dengue fever, influenza, tuberculosis, malaria, Zika virus, chikungunya, pneumonia, and HIV has created a favourable environment for the expansion of the vaccine storage equipment market. However, the environmental con...

 The global analytical standards market is experiencing steady and consistent growth as industries worldwide tighten their focus on accuracy, quality, and regulatory compliance. Starting at US$1.44 billion in 2022 and increasing to US$1.53 billion in 2024, the market is projected to expand at a CAGR of 5.9% between 2024 and 2030. By 2030, it is expected to reach US$2.16 billion, driven by advancements in analytical methods, stringent regulations, and broader application across scientific and industrial sectors. Download PDF Brochure: Market Overview Analytical standards are reference materials with precisely known properties (e.g., composition, purity, concentration) used for calibration, quality control, and method validation in analytical chemistry. They are essential for ensuring the accuracy, reliability, and traceability of analytical measurements. The global analytical standards market encompasses a wide range of products, including organic standards, inorganic standar...